Cyclerion Therapeutics, Inc. (CYCN) DCF Valuation

Cyclerion Therapeutics, Inc. (CYCN) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Cyclerion Therapeutics, Inc. (CYCN) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Cyclerion Therapeutics, Inc. (CYCN) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¿Busca determinar el valor intrínseco de Cyclerion Therapeutics, Inc.? Nuestra calculadora CYCN DCF integra datos del mundo real con extensas características de personalización, lo que le permite refinar sus pronósticos y tomar decisiones de inversión más informadas.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 4.5 2.3 3.3 .3 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -49.06 44.6 -91.05 -100 -48.88 -48.88 -48.88 -48.88 -48.88
EBITDA -122.3 -81.3 -55.2 -18.2 -12.6 .0 .0 .0 .0 .0
EBITDA, % -2714.38 -3539.42 -1662.5 -6121.55 100 -60 -60 -60 -60 -60
Depreciation 2.7 2.3 .5 .1 -2.9 .0 .0 .0 .0 .0
Depreciation, % 59.91 100.04 14.22 21.89 100 59.2 59.2 59.2 59.2 59.2
EBIT -125.0 -83.6 -55.7 -18.2 -9.6 .0 .0 .0 .0 .0
EBIT, % -2774.28 -3639.46 -1676.72 -6143.43 100 -60 -60 -60 -60 -60
Total Cash 94.9 54.4 54.0 13.4 7.6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.5 .1 .1 .1 .0
Account Receivables, % 32.7 5.53 3.01 32.32 100
Inventories 2.0 .8 .9 .8 .0 .0 .0 .0 .0 .0
Inventories, % 43.62 35.54 27.95 271.04 100 61.42 61.42 61.42 61.42 61.42
Accounts Payable 3.3 1.4 1.8 3.0 1.2 .0 .0 .0 .0 .0
Accounts Payable, % 73.46 62.5 55.06 1000 100 78.2 78.2 78.2 78.2 78.2
Capital Expenditure -6.9 -1.5 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -152.83 -66.38 -0.21084 0 100 -33.32 -33.32 -33.32 -33.32 -33.32
Tax Rate, % -66.88 -66.88 -66.88 -66.88 -66.88 -66.88 -66.88 -66.88 -66.88 -66.88
EBITAT -123.0 -78.1 -55.7 -18.1 -16.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -127.3 -76.7 -54.9 -16.8 -19.9 -1.2 .0 .0 .0 .0
WACC, % 13.53 13.53 13.53 13.53 13.53 13.53 13.53 13.53 13.53 13.53
PV UFCF
SUM PV UFCF -1.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -8
Equity Value 7
Diluted Shares Outstanding, MM 2
Equity Value Per Share 2.79

What You Will Get

  • Real CYCN Financial Data: Pre-filled with Cyclerion Therapeutics’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Cyclerion’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Clinical Parameters: Adjust key inputs such as trial success rates, market penetration, and R&D expenditures.
  • Instant Drug Development Valuation: Computes intrinsic value, NPV, and other metrics in real-time.
  • Industry-Leading Precision: Incorporates Cyclerion's actual financial data for accurate valuation results.
  • Effortless Scenario Planning: Evaluate various assumptions and analyze results with ease.
  • Efficiency Booster: Remove the necessity of constructing intricate valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Cyclerion Therapeutics’ pre-filled financial data and forecasts.
  3. Step 3: Modify critical inputs like revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Watch the DCF model update instantly as you tweak assumptions.
  5. Step 5: Analyze the outputs and use the results for investment decisions.

Why Choose This Calculator for Cyclerion Therapeutics, Inc. (CYCN)?

  • User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
  • Customizable Inputs: Modify parameters effortlessly to suit your financial analysis.
  • Real-Time Valuation: Instantly observe changes in Cyclerion's valuation with input adjustments.
  • Preloaded Data: Comes with Cyclerion's actual financial metrics for swift evaluations.
  • Endorsed by Industry Experts: Utilized by investors and analysts for well-informed decision-making.

Who Should Use This Product?

  • Investors: Accurately assess Cyclerion Therapeutics’ fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial analysis and reporting.
  • Consultants: Efficiently customize the template for client valuation reports.
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms.
  • Educators: Implement it as a teaching resource to illustrate valuation techniques.

What the Template Contains

  • Historical Data: Includes Cyclerion Therapeutics’ past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Cyclerion Therapeutics’ intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Cyclerion Therapeutics’ financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.